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1 Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, United States, 2 INSERM, MMG,
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Emerin (EMD) and barrier to autointegration factor 1 (BANF1) each bind A-type lamins
(LMNA) as fundamental components of nuclear lamina structure. Mutations in LMNA,
EMD and BANF1 are genetically linked to many tissue-specific disorders including
Emery-Dreifuss muscular dystrophy and cardiomyopathy (LMNA, EMD), lipodystrophy,
insulin resistance and type 2 diabetes (LMNA) and progeria (LMNA, BANF1). To
explore human genetic variation in these genes, we analyzed EMD and BANF1
alleles in the Exome Aggregation Consortium (ExAC) cohort of 60,706 unrelated
individuals. We identified 13 rare heterozygous BANF1 missense variants (p.T2S, p.H7Y,
p.D9N, p.S22R, p.G25E, p.D55N, p.D57Y, p.L63P, p.N70T, p.K72R, p.R75W, p.R75Q,
p.G79R), and one homozygous variant (p.D9H). Several variants are known (p.G25E)
or predicted (e.g., p.D9H, p.D9N, p.L63P) to perturb BANF1 and warrant further study.
Analysis of EMD revealed two previously identified variants associated with adult-onset
cardiomyopathy (p.K37del, p.E35K) and one deemed ‘benign’ in an Emery-Dreifuss
patient (p.D149H). Interestingly p.D149H was the most frequent emerin variant in
ExAC, identified in 58 individuals (overall allele frequency 0.06645%), of whom 55
were East Asian (allele frequency 0.8297%). Furthermore, p.D149H associated with four
‘healthy’ traits: reduced triglycerides (−0.336; p = 0.0368), reduced waist circumference
(−0.321; p = 0.0486), reduced cholesterol (-0.572; p = 0.000346) and reduced LDL
cholesterol (−0.599; p = 0.000272). These traits are distinct from LMNA-associated
metabolic disorders and provide the first insight that emerin influences metabolism. We
also identified one novel in-frame deletion (p.F39del) and 62 novel emerin missense
variants, many of which were relatively frequent and potentially disruptive including
p.N91S and p.S143F (∼0.041% and ∼0.034% of non-Finnish Europeans, respectively),
p.G156S (∼0.39% of Africans), p.R204G (∼0.18% of Latinx), p.R207P (∼0.08% of
South Asians) and p.R221L (∼0.15% of Latinx). Many novel BANF1 variants are
predicted to disrupt dimerization or binding to DNA, histones, emerin or A-type lamins.
Many novel emerin variants are predicted to disrupt emerin filament dynamics or binding
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to BANF1, HDAC3, A-type lamins or other partners. These new human variants provide
a foundational resource for future studies to test the molecular mechanisms of BANF1
and emerin function, and to understand the link between emerin variant p.D149H and a
‘healthy’ lipid profile.
Keywords: barrier to autointegration factor 1, emerin, laminopathy, LDL cholesterol, triglycerides, progeria,
mechanotransduction
INTRODUCTION
Emerin is a conserved ‘LEM-domain’ component of nuclear
lamina networks, which have central roles in nuclear structure
and function (Simon and Wilson, 2011; Barton et al., 2015;
Gruenbaum and Foisner, 2015). Emerin, an integral membrane
protein, localizes mainly at the inner membrane of the nuclear
envelope (NE) and binds directly to lamins (nuclear intermediate
filaments), LINC complexes and an essential chromatin protein
named BANF1 (Berk et al., 2013b; Jamin and Wiebe, 2015; Janin
et al., 2017). Nuclear lamina proteins have multiple and varied
roles from mitosis to tissue-specific signaling (Gerace and Tapia,
2018). For example, during telophase of mitosis, segregating
daughter chromosomes are coalesced by BANF1 (Dharmaraj and
Wilson, 2017; Samwer et al., 2017). BANF1 then cooperates with
emerin, other LEM-domain proteins and lamins to reassemble
the nucleus (Liu et al., 2000, 2003; Dechat et al., 2004; Margalit
et al., 2005; Barkan et al., 2012; Berk et al., 2013b) and re-
establish tissue-specific 3D genome organization (Zullo et al.,
2012; Demmerle et al., 2013; Harr et al., 2015; Stevens et al., 2017;
van Steensel and Belmont, 2017).
Highlighting these complex roles, missense mutations
in lamins and NE membrane proteins cause tissue-specific
disorders, termed ‘laminopathies’ (Worman and Schirmer, 2015;
Janin et al., 2017). Hundreds of disease-causing variants are
reported for the gene encoding A-type lamins (LMNA; Bonne
et al., 2004; Dittmer and Misteli, 2011). We previously identified
novel LMNA missense alleles at frequencies as high as ∼0.4%
in specific ethnic groups (Florwick et al., 2017) among 60,706
unrelated individuals (Lek et al., 2016). This raised questions
about potential genetic variation in two key lamin-binding
proteins: emerin (EMD) and BANF1 (BANF1).
Emerin is expressed in all tissues and has diverse roles
in signaling, cell proliferation, mechanotransduction,
transcriptional regulation and 3D genome organization
(Demmerle et al., 2013; Le et al., 2016; Iyer et al., 2017; Kirby and
Lammerding, 2018). Emerin is specifically important in striated
muscle (Barton et al., 2015; Iyer et al., 2017), since loss of emerin
causes X-linked recessive EDMD1 (Bonne et al., 2004). EDMD1
is characterized by early contractures of the Achilles, elbow, and
neck tendons, progressive muscle weakness and wasting, and
dilated cardiomyopathy that can lead to sudden and potentially
lethal cardiac arrest. In cardiomyocytes, loss of emerin enhances
MAP kinase-dependent gene expression, perturbing heart
Abbreviations: BANF1, Barrier to autointegration factor 1; EDMD, Emery-
Dreifuss muscular dystrophy; LEM-domain, LAP2-Emerin-MAN1 domain; LINC,
linkers of the nucleoskeleton and cytoskeleton; T2D, type 2 diabetes; TCGA, The
Cancer Genome Atlas. WT, wildtype.
physiology (Muchir et al., 2007; Huber et al., 2009; Stubenvoll
et al., 2015). The same disease, EDMD, is also linked to mutations
in proteins that bind emerin including A-type lamins, nesprin-1,
nesprin-2, Sun1, Sun2 and LUMA/Tmem43 (Dobrzynska et al.,
2016; Pillers and Von Bergen, 2016).
Emerin specifically mediates nuclear responses to mechanical
force (Lammerding et al., 2005; Le et al., 2016; Qi et al., 2016;
Lele et al., 2018), particularly on stiff substrates (Willer and
Carroll, 2017). Emerin is needed to activate mechanoresponsive
genes (Lammerding et al., 2005; Le et al., 2016), influences
cytoskeletal F-actin networks (Chang et al., 2013) and regulates
the SRF-Mkl1 coactivator complex on stiff substrates (Ho et al.,
2013; Willer and Carroll, 2017). ‘Pulling’ forces applied to
LINC complexes on isolated nuclei cause Tyr-phosphorylation of
emerin at unidentified sites, dependent on the integrity of two
Tyr residues targeted by Src (emerin Y74 and Y95; Tifft et al.,
2009; Guilluy et al., 2014). However, the mechanisms by which
emerin, an intrinsically disordered ‘transformer’ protein (Samson
et al., 2016), senses force and signals in response to force are
open questions. Emerin has at least two modes of self-association
with the potential to form networks or filaments (Berk et al.,
2014; Herrada et al., 2015; Samson et al., 2017). Other partners
include nucleo/cytoskeletal proteins (e.g., F-actin, myosin 1c,
tubulin), nuclear membrane proteins (e.g., LAP1, Samp1) and
transcriptional regulators such as HDAC3, b-catenin and Lmo7
(Holaska et al., 2006; Berk et al., 2013b; Shin et al., 2013; Barton
et al., 2015; Vijayaraghavan et al., 2018).
Additional partners and roles for emerin are emerging in
disparate tissues. For example, emerin, BANF1 and lamin A/C
associate with the sigma-1 receptor in neurons; association is
enhanced by the sigma-1 receptor agonist, cocaine, leading to
transcriptional repression of a gene, MAOB1, the product of
which degrades dopamine (Tsai et al., 2015). The bacterium
Chlamydia psittaci, which causes rapid and potentially lethal
pneumonia, targets emerin and emerin-associated nuclear
membrane proteins (Mojica et al., 2015). In models of breast
and prostate cancer, loss of emerin correlates with increased
metastatic potential (Hu et al., 2011; Wozniak et al., 2013; Reis-
Sobreiro et al., 2018). Mechanisms and partners for emerin in
these contexts are unexplored.
To our knowledge, only one BANF1 variant is reported
in humans. This variant, p.A12T, was identified in two
homozygous individuals and genetically linked to Nestor-
Guillermo progeria syndrome (Puente et al., 2011). This variant
perturbs BANF1 binding to dsDNA (Paquet et al., 2014) and
weakens BANF1 binding to a progeria-related surface on the
Ig-fold domain of lamins A and C (Samson et al., 2018).
BANF1 is the conserved partner for all LEM-domain proteins
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(Laguri et al., 2001), and also binds lamins (Holaska et al., 2003;
Samson et al., 2018). Indeed, BANF1 can bind emerin and
lamin A simultaneously (Bengtsson and Wilson, 2006; Samson
et al., 2018). BANF1 is essential during mitosis: BANF1 collects
segregating chromosomes within a single nucleus (Samwer
et al., 2017; Dharmaraj and Wilson, 2017) and coordinates with
lamins and LEM-domain proteins to reassemble nuclear lamina
structure (Haraguchi et al., 2008; Simon and Wilson, 2011).
BANF1 is mislocalized in cells that express disease mutations
in lamin A (Capanni et al., 2012) and is immobilized by fasting
(Bar et al., 2014). BANF1 is an epigenetic regulator (Montes de
Oca et al., 2011; Oh et al., 2015) and has roles in chromatin
organization (Loi et al., 2015), antiviral defense (Kobayashi
and Haraguchi, 2015; Wiebe and Jamin, 2016), suppression
of endoreplication (Brayson et al., 2018; Wang et al., 2018)
and necrotic pyknosis (Hou et al., 2016). BANF1 regulates the
insertion of endogenous mobile elements in eukaryotic genomes;
this activity is exploited by retroviruses including HIV-1 (Harris
and Engelman, 2000; Wang et al., 2014; Jamin and Wiebe, 2015).
DNA sequencing of human populations has the potential
to reveal novel phenotypes or missense variants in specific
proteins-of-interest, as sources of insight and information for
mechanistic studies. This strategy, applied to the gene encoding
A-type lamins (LMNA), revealed unexpectedly high frequencies
of disease-causing LMNA alleles in specific ethnic groups, and
linked a specific missense variant to type 2 diabetes (Florwick
et al., 2017). Other key components of nuclear lamina structure,
emerin (EMD) and BANF1 (BANF1), were unexplored. We
therefore analyzed EMD and BANF1 variants in the Exome
Aggregation Consortium (ExAC) cohort of 60,706 unrelated
individuals (Lek et al., 2016), which includes exome sequences
from men and women with diverse ancestries (8.6% African, 9.5%
Latinx, 7.1% East Asian, 5.4% Finnish, 55% non-Finish European,
13.6% South Asian, 0.7% other). About half of these individuals
either have a specific condition (heart disease, type 2 diabetes,
schizophrenia or other disorders) or serve as controls for each
condition. We anticipated few loss-of-function EMD alleles,
since ExAC excludes individuals with severe childhood-onset
disorders such as EDMD1. We anticipated few alleles for BANF1,
given its conservation and essential roles (Zheng et al., 2000;
Montes de Oca et al., 2005; Samwer et al., 2017). Highlighting
the value of population diversity represented in ExAC, we
identified 14 novel BANF1 missense alleles and many novel
EMD alleles, ten of which were relatively frequent in specific
ethnic populations. We discovered that emerin variant p.D149H,
identified in 0.8% of East Asians, associates with a healthy
lipid profile including reduced triglycerides and reduced LDL
cholesterol. Our detailed structure-function analysis predicts that
many identified BANF1 and emerin variants are potentially
disruptive and warrant further study.
MATERIALS AND METHODS
ExAC Database Searches
Version 0.3.1 ExAC was queried for ‘EMD’ and ‘BANF1’
via the ExAC Browser (Beta), selecting only for variants
that passed the quality assurance filter (Lek et al., 2016;
ExAC database, 2018). The data was narrowed to include
in-frame deletions and missense, synonymous and splice
variants, and exported in the .csv file format. To identify
variants associated with broadly defined ‘psychiatric disease’
(schizophrenia, bipolar disorder, Tourette syndrome), we
compared two variant call files from ExAC version 0.3. The
first file (ExAC.r0.3.sites.vep.vcf) contained all ExAC variants;
the second file (ExAC.r0.3.nonpsych.sites.vcf) contained all
variants not found in the psychiatric cohort. By subtracting
the ‘nonpsych’ variants from the full cohort using the UNIX
‘comm’ tool in a shell script, further selecting for emerin and
BANF1 alleles, and manually curating the final list to handle
the consequences of minimal and multi-allelic representation,
we were able to generate a file of emerin and BANF1 variants
unique to the psychiatric cohort. To subset against TCGA,
we subtracted the variants not reported in the TCGA dataset
(ExAC_nonTCGA.r0.3.1.sites.vep.vcf) from the full cohort to
generate a list of potentially ‘cancer-unique’ alleles.
Laminopathy Database
To search for previously identified variants, we queried
the Universal Mutation Database and the Leiden Muscular
Dystrophy Pages (powered by Leiden Open Variation Database
v2.0; accessed September 2018) for EMD variants. After curating
to exclude all non-missense mutations and non-canonical
spliceforms, only three variants were shared with ExAC.
Type 2 Diabetes (T2D) Knowledge Portal
Since we were unable to determine the clinical status of variant
carriers in ExAC, we searched the open-access Type 2 Diabetes
Knowledge Portal for EMD variants. ‘Associations across all
datasets’ for each ExAC EMD variant were obtained using the
variant ID or reference SNP ID (rs) as the search term in the
T2D portal1. The only protein-coding variant with significant
and ‘high-impact’ associations (p.D149H) was identified solely
within the 13K Exome Sequence Analysis cohort, which includes
samples from 13,007 individuals (half with T2D, half controls)
representing five ancestries: European (∼5,000 individuals),
African-American, East Asian, South Asian and Hispanic
(∼2,000 individuals each). All p.D149H-related statistics come
from the analysis reported in the T2D Knowledge Portal.
Statistical Analysis to Query Potential
Sex Distribution Bias
To determine if the sex distribution of variants differed from their
expected distribution, we calculated expected distributions based
on the ExAC sampling of the sex distribution for each ethnic
sub-group in which the allele was most concentrated as a first
approximation. For example, the allele producing variant p.N91S
was found in 19 individuals of non-Finnish European (nFE)
ethnicity, so the proportion of males in the nFE sample of ExAC
(56.16%) was used to estimate the expected male allele frequency.
To compare the expected versus observed sex distributions, we
1http://www.type2diabetesgenetics.org/variantInfo/variantInfo/X_
153609158_G_C
Frontiers in Cell and Developmental Biology | www.frontiersin.org 3 April 2019 | Volume 7 | Article 48
fcell-07-00048 April 3, 2019 Time: 21:25 # 4
Dharmaraj et al. BANF1 and EMD in ExAC
conducted a chi-squared goodness-of-fit test with 1 degree of
freedom. No differences in male/female distribution were found
to be significant. Even p.R207P, identified only in men, was
explained by a very high proportion of males in the South Asian
subgroup where this allele was concentrated.
Disorder Prediction
To predict intrinsically disordered regions in ExAC variants,
variant emerin sequences were submitted as queries to PONDR-
FIT VL-XT2. Raw VL-XT output scores are real numbers from 0
to 1, where 0 is ‘order’ and 1 is ‘disorder,’ and were plotted.
Hydrophobicity and Helical Wheel Plots
Kyte-Doolittle hydrophobicity plots3 were used to assess the
impact of variants located in the C-terminal transmembrane
domain. Helical wheel projections showing the positions of
variants in the emerin transmembrane domain (residues 226–
244) were generated using the Emboss pepwheel tool with default
settings4. 1G values for the insertion of transmembrane helices
into membranes were calculated using the 1G prediction server
v1.05 (Hessa et al., 2007).
Structural Depictions
PyMOL version 2.2 was used to generate ray-traced images of
the solution NMR structure of the emerin LEM domain (RCSB
Protein Data Bank ID: 2ODC) and the crystal structure of
BANF1 in complex with the emerin LEM domain (RCSB Protein
Data Bank ID: 2ODG).
RESULTS
ExAC results for BANF1 are presented first, followed by emerin
variants for which we provide allele frequencies, molecular
analysis and clinical phenotype.
BANF1 Variants in ExAC
We were frankly surprised to find 14 BANF1 missense
alleles, one predicted splice acceptor allele and one frameshift
allele (p.F59PfsTer50) in ExAC (Table 1 and Supplementary
Table S1). The frameshift (p.F59PfsTer50) and splice acceptor
alleles are likely to yield unstable polypeptides, and were not
considered further. Missense variant p.S22R was identified in
three individuals (all African), for an allele frequency of 0.02905%
in Africans. All other BANF1 missense variants were limited
to one or two individuals and, surprisingly, one individual was
homozygous for the variant identified (p.D9H; Table 1). We also
evaluated 3′-UTR alleles of BANF1 (Supplementary Table S1)
because this region is functionally important in cervical cancer,
where BANF1 mRNA is suppressed by miRNA-203 via binding
to 3′-UTR nucleotides 138–159 (Mao et al., 2015). This site
was not affected by BANF1 3′-UTR alleles in ExAC, but might
2http://www.pondr.com
3https://web.expasy.org/protscale/
4http://emboss.bioinformatics.nl/cgi-bin/emboss/pepwheel
5http://dgpred.cbr.su.se/index.php?p=TMpred
TABLE 1 | BANF1 missense, splice acceptor site and frameshift alleles
identified in ExAC.
Variant Allele count Comments (ethnic allele frequency)
c.-16-1G > C 1 Splice acceptor site; Finnish (0.01518%)
p.T2S 1 Missense; nF-European (0.001510%)
p.H7Y 2 Missense; 2/2 nF-European (0.003015%)
p.D9N 2 Missense; 2/2 nF-European (0.003013%)
p.D9H 2 Missense; 1 homozygous S. Asian (0.01213%)
p.S22R 3 Missense; 3/3 African (0.02905%)
p.G25E 1 Missense; nF-European (0.001503%)
p.D55N 1 Missense; nF-European (0.001498%)
p.D57Y 1 Missense; Latinx (0.008639%)
p.F59PfsTer50 1 Frameshift; Latinx (0.008639%)
p.L63P 1 Missense; African (0.009612%)
p.N70T 1 Missense; South Asian (0.006057%)
p.K72R 1 Missense; nF-European (0.001498%)
p.R75W 1 Missense; Latinx (0.008642%)
p.R75Q 2 Missense; 2/2 nF-European (0.002997%)
p.G79R 1 Missense; nF-European (0.001499%)
be affected by 3′-UTR alleles reported in the dbSNP database:
c.∗143T > C (rs1478691828), c.∗144C > T (rs1366306879),
c.∗146C > G (rs535232397), c.∗152C > T (rs1442694445). In
summary, we identified 14 BANF1 missense variants; all were
novel in biology, and most are non-conservative substitutions
that might perturb function.
Two BANF1 missense variants are considered disruptive.
Variant p.L63P is likely to disrupt BANF1 folding or
dimerization, since WT Leu63 is buried in helix a4 (Figure 1,
Ribbon view); whether the resulting protein is degraded or stable
is unknown. Interestingly, variant p.G25E was previously created
in vitro to disrupt BANF1 dimerization: the resulting protein
is stable as a monomer, shows no detectable binding to DNA,
histones or emerin (Umland et al., 2000; Montes de Oca et al.,
2005), and did not disrupt higher-order chromatin structure
in Xenopus egg extracts (Segura-Totten et al., 2002). When
over-expressed in HeLa cells, however, GFP-fused BANF1-G25E
interfered with the telophase ‘core’ localization and post-mitotic
re-assembly of emerin, LAP2β and lamin A (Haraguchi et al.,
2001). Whether p.G25E behaves dominantly or recessively when
co-expressed at normal levels with WT BANF1 is unknown.
The other 12 BANF1 missense variants all affect surface-
exposed residues (Figure 1), allowing us to evaluate potential
molecular impacts. Figure 1 shows ‘front,’ ‘top,’ ‘bottom’ and
‘side’ views of BANF1. WT residues affected by ExAC variants
are colored blue in one subunit, yellow in the other subunit
(Figure 1). Variants p.D55N and p.D57Y are non-conservative
substitutions visible on the ‘front’ and ‘side’ surfaces (Figure 1);
the role of the ‘front’ surface is unclear, but may influence binding
to histones (Montes de Oca et al., 2005). ExAC variants p.H7Y,
p.D9N, p.D9H and p.S22R probably affect the integrity of the
‘top’ surface, but are different from residues (e.g., V11, A12,
P14, E83, D86, A87, F88) that contact the Ig-fold of lamins A/C
(Samson et al., 2018). Variants p.D9N and p.D9H are potentially
more disruptive than an in vitro mutation (p.D9A) that reduced
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FIGURE 1 | Wildtype BANF1 residues affected by novel ExAC missense variants. Crystal structure (Umland et al., 2000) of the BANF1 dimer showing wildtype
residues affected by novel ExAC variants (RCSB Protein Data Bank ID: 1CI4). ‘Top’ and ‘Bottom’ views were obtained by rotating the ‘Front view’ 90◦ along its long
axis out of, and into, the page respectively. ‘Side view’ shows the DNA-binding surface of BAF and was obtained by rotating the Front view 90◦ to the right. Wildtype
residues affected by ExAC variants are colored blue in the pale-gray subunit, and yellow in the dark-gray subunit. Plain and ‘prime’ numbers indicate affected
residues in the pale-gray and dark-gray subunits, respectively. Ribbon depiction of the ‘Front view’ reveals residues involved in the dimer interface, and a buried
α-helical residue that we predict is disrupted by variant p.L63P.
binding to DNA, histones and emerin (Umland et al., 2000;
Montes de Oca et al., 2005), but retained the ability to hyper-
condense chromatin (Segura-Totten et al., 2002). No variants
affected residues on the ‘bottom’ surface (Figure 1), which binds
the LEM-domain (via BANF1 residues R37, F39, Q48, V51, L52,
L58, E61 and W62; Samson et al., 2018). Interestingly most ExAC
variants (e.g., p.H7Y, p.D9N, p.D9H, p.S22R, p.D57Y, p.N70T,
p.R75W, p.R75Q, p.G79R) are likely to perturb the ‘side’ surface
(Figure 1), responsible for binding to DNA (via BANF1 residues
K6, G25, G27, V29 and L30, aided by S4, Q5, A71 and R75
(Bradley et al., 2005); two variants (p.R75W, p.R75Q) affected a
residue involved in DNA contact. A previously studied in vitro
substitution, p.R75E, reduced binding to DNA and emerin, but
enhanced binding to histones (Montes de Oca et al., 2005).
Further studies are needed to determine if any of these novel
variants affect BANF1 dimerization, binding to histones, BANF1-
dependent epigenetic regulation (Montes de Oca et al., 2009,
2011) or other roles (Jamin and Wiebe, 2015).
Emerin Variants in ExAC
Overall, EMD alleles were considered rare (defined as < 1%
of the entire ExAC population), comprising 42 synonymous
alleles, six nucleotide changes in splice regions with no
suggested consequence, 64 missense alleles and two in-frame
deletions (Supplementary Table S2). No EMD alleles associated
with either cancer or broadly defined psychiatric disease, as
determined by subsetting respectively against TCGA and the
psychiatric disease cohort in ExAC (see Materials and Methods).
Emerin is encoded by an X-linked gene, which allowed us
to assess variant distributions in men (hemizygous) versus
women (heterozygotes). No EMD alleles were homozygous
(Supplementary Table S2). A potential sex-distribution bias
of two variants, p.G156S and p.R207P, which appeared to be
enriched in women and men, respectively, was an artifact of
skewed representation of women versus men in specific ethnic
groups (see Materials and Methods).
Further analysis focused on EMD missense and in-frame
deletion alleles (henceforth ‘variants’); 39 variants were unique
(identified in a single individual; Supplementary Table S2) and
27 were identified in two or more (up to 58) individuals (Table 2).
The positions of all 66 variants with respect to the amino acid
sequence of emerin are depicted in Figure 2A, with bar heights
indicating the number of affected individuals. Residues known to
be involved in self-association, filament formation or binding to
BANF1, lamin A or nesprins are also depicted (Figures 2B–I).
Three Emerin ExAC Variants (p.K37del,
p.R203H, p.D149H) Reported in
Laminopathy Database
We anticipated little overlap with the laminopathy database, since
severe childhood-onset disorders such as EDMD1 are excluded
from ExAC (Lek et al., 2016). Indeed, only three emerin ExAC
variants were previously reported in the laminopathy database:
p.K37del, p.R203H and p.D149H. Variant p.K37del causes the
loss-of-function EDMD1 phenotype even though the resulting
protein is expressed at normal or near-normal levels (Ellis
et al., 1998). Loss of residue K37 destabilizes the LEM-domain
(Samson et al., 2017), reduces affinity for BANF1 (Essawy et al.,
personal communication) and accelerates the rate of emerin
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TABLE 2 | EMD missense and in-frame-deletion alleles identified in 2+
individuals in ExAC.
Variant # Individuals Allele
frequency (%)
Ethnic concentration∗
p.K37del 2 0.002529 n/a
p.P50S 2 0.002547 n/a
p.N91S 19 0.02236 19/19 nF-European (0.04123%)
p.G112C 2 0.002333 n/a
p.R118H 2 0.002333 n/a
p.A129T 2 0.002336 n/a
p.D138N 2 0.002294 n/a
p.S143F 16 0.01834 16/16 nF-European (0.03365%)
p.E146K 2 0.002291 n/a
p.D149H 58 0.06645 55/58 East Asian (0.8297%)
p.R152C 3 0.003436 3/3 nF-European (0.0066298%)
p.P153L 5 0.005726 3 ethnicities∗∗
p.G156S 34 0.03893 33/34 African (0.3894%)
p.G156R 9 0.01031 9/9 nF-European (0.01889%)
p.R157Q 7 0.008016 5/7 nF-European (0.01049%)
2/7 Latinx (0.02149%)
p.S194L 3 0.003433 3/3 South Asian (0.02964%)
p.W200R 2 0.00229 n/a
p.R203H 4 0.00458 3/4 East Asian (0.04527%)
p.R204G 17 0.01947 17/17 Latinx (0.1826%)
p.R204C 3 0.003436 3/3 nF-European (0.006296%)
p.R207P 8 0.009166 8/8 South Asian (0.07917%)
p.G216R 9 0.01033 9/9 African (0.1064%)
p.R221L 14 0.0161 14/14 Latinx (0.1505%)
p.P224L 2 0.002301 n/a
p.W226S 2 0.002303 n/a
p.V238I 3 0.003477 2/3 nF-European (0.004255%),
1/3 Latinx (0.01078%)
p.E249G 3 0.00361 3/3 nF-European (0.006632%)
∗n/a, not applicable; calculated only for alleles identified in 3 or more individuals.
∗∗2 European (0.04423%); 2 nF-European (0.004198%); 1 Other (0.1592%).
self-association as filaments in vitro (Samson et al., 2017). Finding
two individuals with p.K37del in ExAC was plausible because
this variant is known to cause isolated cardiac disease in adult
men (hemizygous) and women (heterozygous; Ben Yaou et al.,
2007), and cardiac disease is well-represented in ExAC (Lek et al.,
2016). A similar case can be made for variant p.R203H (identified
in four ExAC individuals), because the only reported EDMD1
patient with this variant showed cardiac symptoms as an adult
(39 years; Funakoshi et al., 1999). These results were encouraging
in their suggestion that ExAC populations might also include
novel variants that specifically affect the heart.
The third ‘known’ variant, p.D149H, was reported in one
EDMD1 patient but nevertheless deemed benign with respect
to laminopathy. This was exciting because p.D149H was the
most-frequent EMD variant in ExAC and associated with a novel
metabolic phenotype, as described below.
Ethnic Concentrations of the Most
Frequent Emerin Variants in ExAC
The most frequent emerin variants in ExAC, including nine
novel variants, each concentrated in a specific ethnic group
(Table 2 and Supplemental Table S2). Topping the list was
variant p.D149H, identified predominantly in East Asians (55
of 58 individuals) with an allele frequency of 0.8297% in
East Asians; the other individuals were South Asian (one)
and Latino (henceforth ‘Latinx’; two). Non-Finnish Europeans
(henceforth, ‘Europeans’), the largest ethnic population in
ExAC, also had the greatest overall number of emerin variants
(Table 2). Three variants were identified only in Europeans:
p.N91S (all 19 individuals; allele frequency 0.04123%), p.S143F
(all 16 individuals; allele frequency 0.03365%) and p.G156R
(all 9 individuals; allele frequency 0.01889%), corresponding
to frequencies of 1.8 to 4.1 per 10,000 individuals. Variant
p.R157Q was identified predominantly in Europeans (5 of 7
individuals; allele frequency 0.01049%); the other two were
Latinx. Variant p.G216R was identified only in Africans (all
9 individuals; allele frequency 0.1064%). Variant p.G156S was
identified predominantly in Africans (33 of 34 individuals;
allele frequency 0.3894%); the other individual was European.
Two variants were identified only in Latinx: p.R204G (all
17 individuals; allele frequency 0.1826%) and p.R221L (all
14 individuals; allele frequency 0.1505%). Variant p.R207P
was identified only in South Asians (all 8 individuals; allele
frequency 0.07917%). In other words, six variants (p.D149H,
p.G156S, p.R204G, p.R207P, p.G216R, p.R221L) were identified
at frequencies of 10–83 per 10,000 individuals in specific
populations. Note that these frequencies may be skewed by
multiple factors including distribution artifacts and potential
association with disorders (e.g., cardiomyopathy or type 2
diabetes) that are enriched in ExAC.
Variant p.D149H, Identified in 0.8297% of
East Asians, Associates With a ‘Healthy’
Lipid Profile
Variant p.D149H was identified 58 times in ExAC with allele
frequencies of 0.0665% overall and 0.8297% in East Asians
(Table 2 and Supplementary Table S2). For most disorders,
ExAC does not link individuals to clinical phenotypes. However,
ExAC includes type 2 diabetes cohorts for whom clinical data
is accessible via the T2D Knowledge Portal6. To determine
if any variants associated with a metabolic phenotype(s),
we searched within 100 kb of EMD (see Materials and
Methods). We found no significant associations with body-
mass index, diastolic blood pressure, fasting glucose, fasting
insulin, glycated hemoglobin (HbA1c), HDL cholesterol, height,
hip circumference, systolic blood pressure, type 2 diabetes or
waist-hip ratio. By contrast, four traits showed a significant
association with emerin variant p.D149H: reduced triglycerides
(effect was −0.336; p = 0.0368), reduced waist circumference
(effect was −0.321; p = 0.0486), reduced cholesterol (effect
was −0.572; p = 0.000346) and reduced LDL cholesterol
(effect was −0.599; p = 0.000272). We concluded that
emerin variant p.D149H specifically influences metabolism
(see Discussion).
6http://www.type2diabetesgenetics.org/
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FIGURE 2 | Schematic summary of all identified emerin missense and in-frame deletions in ExAC in relation to functional regions of emerin. (A) Amino acid sequence
of wildtype emerin. Y-axis shows the number of variant alleles at each position (‘Allele count’). Each black dot indicates one affected individual. Some variants are
named; for a full list see Supplementary Table S2. Black bars indicate the LEM-domain (Cai et al., 2007) and transmembrane domain (‘TMD’). (B) Peptides that
mediate intermolecular self-association (Berk et al., 2014). Gray bars indicate three peptides specifically recognized by emerin residues 170–220, named the
‘LEM-peptide’ (residues 34–53), ‘SAYQS region’ (residues 147–174) and ‘R-peptide’ (residues 206–225). (C-E) Regions involved in the assembly of curvilinear
filaments in vitro (Herrada et al., 2015; Samson et al., 2018). (C) Gray bars indicate regions that form filaments either slowly (residues 1–132 or 1–187) or rapidly
(residues 67–221) in vitro. (D) Gray bars depict residues that resist digestion with protease, thereby identified as backbone (protected) components of emerin
filaments. (E) Gray bars depict residues 1–66, critical for (slow) self-assembly of LEM-containing constructs, and residues 188–221, critical for (rapid) self-assembly
of residues 67–221. (F) Gray bar indicates residues sufficient to bind BANF1 in vitro. (G) Gray bar indicates residues deduced as sufficient to bind mature lamin A
residues 385-646 and, with lower affinity to lamin B1 residues 395–586 (Berk et al., 2014). (H) Gray bar indicates a second region of emerin that independently binds
mature lamin A residues 385–646 and, with lower affinity to lamin B1 residues 395–586 (Berk et al., 2014). (I) Gray bar indicates residues sufficient to bind either
nesprin-1 or nesprin-2 in vitro (Wheeler et al., 2007). Not depicted: Sun1 and Sun2 bind via deduced emerin residues 134–221 (Haque et al., 2010).
‘Top-Ten’ Emerin Variants in Regions
That Self-Associate and Bind Lamin A
and Nesprins
Variant p.N91S is a disruptive mutation in a core (protease-
protected) region of emerin filaments (Figure 2D) that also binds
lamin A (Figure 2G). Other ‘top-ten’ variants clustered in two
regions: variants p.S143F through p.R157Q affect residues in
the ‘SAYQS’ region, while variants p.R203H through p.R221L
affect residues in the ‘R-peptide’ region, near the transmembrane
domain (TMD; Figure 2B). Both regions mediate emerin self-
association, as shown in peptide binding studies (Figure 2B;
Berk et al., 2014) and biophysical studies of emerin filaments
(Figures 2C,D; Herrada et al., 2015; Samson et al., 2017).
Both regions also directly bind lamin A (Figure 2H), nesprins
(Figure 2I) and other partners (Berk et al., 2014). The
substitutions created by variants p.D149H, p.P153L, p.R204G and
p.R207P are predicted to perturb one or more of these functions
(see Discussion).
LEM-Domain Variants: One Known
(p.K37del) and Three Novel (p.G28A,
p.E35K, p.F39del)
Four LEM-domain variants were identified in ExAC: the
cardiomyopathy-associated variant p.K37del (discussed above)
and three unique novel variants: p.G28A, p.E35K and p.K39del
(Supplementary Table S2). WT LEM-domain residues affected
by ExAC variants are depicted via surface view (Figure 3A)
and ribbon diagram (Figure 3B; PDB code 2ODC; Cai et al.,
2007). All four WT residues are surface-exposed (Figure 3A)
on the large α-helix (Figure 3B). Residues K35, K37, and
F39 each stabilize the α-helix (Figure 3C). Deletion of residue
K37 destabilizes the LEM-domain (Samson et al., 2017); we
therefore expect the same or worse for variant p.F39del, which
is predicted to enhance disorder more than p.K37del (Figure 4).
Missense variant p.E35K, which replaces a negative charge (Glu)
with a positive charge (Lys), is predicted to increase disorder
for residues 21–29 and 35–49 (Figure 4) and thus has the
potential to destabilize the LEM-domain. Variant p.G28A is
positioned to alter the ‘left’ surface of the LEM-domain (as
viewed in Figure 3A). A more-disruptive substitution, p.G28R, is
reported for three individuals in the dbSNP database (Praxis fuer
Humangenetik Teubingen; ID: rs1064797380). The functions of
this surface are unclear, since BANF1 binds the other (‘right’)
side (as viewed in Figure 3A) via direct contact with LEM-
domain residues Y34 (colored yellow; Figures 3A,B), T13, G24,
P25, V27, S29, T30, L33, K36, and K37 (Cai et al., 2007; Samson
et al., 2018). Intriguingly, this ‘mystery’ surface of the LEM-
domain includes α-helical residues Y34 through R47, which
together with disordered residues L48-S53 comprise the ‘LEM-
peptide,’ which mediates emerin self-association (Figure 2B) and
is largely protease-resistant in the context of emerin filaments
(Figure 2D; Samson et al., 2017). Thus, novel ExAC variants
p.G28A and p.E35K, along with p.G28R, are predicted to
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FIGURE 3 | Solution NMR structure (Cai et al., 2007) of the ‘LEM’ domain showing residues affected by ExAC variants (RCSB Protein Data Bank ID: 2ODC). Surface
depiction (A) and ribbon depiction (B) of the wildtype LEM domain. Residues affected by ExAC variants p.G28A, p.E35K, p.K37del and p.K39del are shown in blue.
Also depicted in yellow for reference is Tyr34, which directly contacts BANF1 (Cai et al., 2007; Samson et al., 2018). (C) A helical projection suggests the longest
α-helix, known to be destabilized by p.K37del, is also perturbed by novel variants p.E35K and p.K39del.
disrupt a conformational change(s) of the LEM-domain that
contributes to emerin filament formation, and might also reduce
emerin affinity for lamin A, which binds preferentially to emerin
filaments (Samson et al., 2018).
Variants That Perturb Intrinsic Disorder,
a Fundamental Property of Emerin
Beyond the LEM-domain, emerin is dominated by intrinsic
disorder, as shown by biophysical analysis of emerin residues
50–132 and residues 67–170 (Samson et al., 2016). Disorder
is an important quality that allows such ‘transformer’ proteins
to bind specific partners with high affinity, and to undergo
regulated conformational changes that create new ‘platforms’
for different sets of partners (Uversky, 2011; Wright and
Dyson, 2015; Ruan et al., 2018). About 30% of emerin variants
in ExAC were predicted by PONDR VL-XT to increase
or decrease disorder (Figure 4). Variants p.P50H, p.S54C,
p.S57F, and p.S58F are all predicted to reduce or eliminate
disorder near the LEM-domain (Figure 4); interestingly, their
proximity to known phosphorylation and O-GlcNAcylation
sites (e.g., S55, S56, S60, S62) suggests they might also
interfere with posttranslational control of this proposed ‘hinge’
region (Roberts et al., 2006; Berk et al., 2013a,b). Variant
p.S54C, identified in one individual in ExAC, is a novel
substitution at residue Ser54. A different substitution, p.S54F,
disrupts binding to HDAC3 (Demmerle et al., 2012) and other
partners (Berk et al., 2013b) and is sufficient to cause EDMD1
(Ellis et al., 1998).
Several novel variants were also predicted to either reduce
(p.R152C, p.R152H, p.P153L) or eliminate disorder (p.R157W)
in the conserved ‘SAYQS’ region (Figure 4), which mediates
emerin self-association (Figures 2B–D) and binding to nesprins
(Figure 2I). Seven novel variants (p.S176F, p.S186F, p.S192F,
p.S196F, p.R203C, p.R204C, p.R211C) are predicted to eliminate
disorder in the distal region (Figure 4) that is both sufficient
for binding to lamin A (Figure 2H) and critical for emerin
self-association (Figures 2B–E). Most such variants were
identified in only one individual each, except p.R152C and
p.R204C (three individuals each) and p.P153L (five individuals;
Supplementary Table S2). These variants warrant further study
(see Discussion).
Emerin Variants in Regions Needed for
TRC40-Dependent Membrane Insertion
The hydrophobic C-terminal domain of emerin is recognized by
the Transmembrane Recognition Complex 40 (TRC40) pathway
for posttranslational insertion into ER membrane (Pfaff et al.,
2016). Emerin then diffuses to the NE inner membrane and
is retained by binding to A-type lamins (Östlund et al., 2006)
and nesprins (Wheeler et al., 2007; Zhang et al., 2007). Several
variants including p.L233P, p.F235S and p.Y243S had slightly
reduced Kyte-Doolittle hydrophobicity relative to WT emerin
(Figure 5A), and less favorable (but still negative) 1G values
for transmembrane helix insertion (Figure 5B). Helical wheel
projections of transmembrane residues 226–244 (Figure 5C)
showed that variants p.W226S, p.V236M and p.F240L affect
conserved residues (Pfaff et al., 2016). Other substitutions
(p.L233P, p.F235S, p.Y243S) are likely to disrupt features
needed for TRC40-dependent insertion (Figure 5C). These
predictions warrant future testing, since most current knowledge
about emerin insertion into membranes is based on EDMD-
associated frameshifts or deletions that truncate or remove the
transmembrane domain (Pfaff et al., 2016). TRC40-dependent
insertion is also significantly (∼44%) reduced by EDMD-causing
variants p.P183T and p.P183H, located ∼40 residues upstream
of the transmembrane domain, through unknown mechanisms
(Pfaff et al., 2016). ExAC variants in this upstream region
were rare (four unique variants between residues 158–193;
Supplementary Table S2). Specific TRC40-dependent targeting
to the ER/NE (rather than mitochondria or peroxisomes)
requires negatively charged residues on the lumenal C-terminus
(Costello et al., 2017; Figueiredo Costa et al., 2018). Emerin has
two such residues, one of which is neutralized by variant p.E249G,
identified in three individuals in ExAC (Figure 2). We speculate
that emerin p.E249G might be inefficiently targeted to the ER/NE,
and end up in the wrong organelle.
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FIGURE 4 | Intrinsic disorder predictions for selected ExAC variants, relative
to wildtype emerin (WT). Disorder predictions from PONDR-FIT VL-XT are
graphed on the Y-axis: disorder increases above the horizontal line and
decreases below the line. The X-axis indicates amino acid positions in emerin.
DISCUSSION
Population diversity in ExAC was key to discovering many
novel variants in the genes encoding emerin and BANF1. The
first thing to keep in mind is that most or all of the EMD
and BANF1 alleles in ExAC could be phenotypically silent, a
common theme in human genetics. However as highlighted in
this report, certain variants have the potential to perturb emerin
or BANF1 at the molecular level. Because EMD is X-linked,
men will express the variant emerin exclusively, increasing the
possibility of a clinical phenotype. Women express EMD variants
exclusively in about 50% of cells, increasing their genetic risk if
the variant perturbs emerin function in cardiomyocytes. Novel
human variants identified in this study provide new tools to study
their molecular roles and potential association with adult-onset
heart disease or new physiological roles, as reported here for
‘healthy lipid’ emerin variant p.D149H. We discuss our results
for BANF1 first.
Human BANF1 Variants: Novel and Rare
BANF1 was first discovered as a protein essential for retroviral
integration into the genome (Lee and Craigie, 1998). Its atomic
structure (obligate dimer) and binding sites for dsDNA (two) and
the LEM-domain are solved (Bradley et al., 2005; Cai et al., 2007).
Residues involved in binding to dsDNA, histone H3, histone H1
or emerin were characterized by in vitro mutagenesis (Umland
et al., 2000; Segura-Totten et al., 2002; Montes de Oca et al.,
2005). Consistent with its essential roles in mitosis, we found that
genetic variation in BANF1 was constrained. BANF1 had a loss-
of-function intolerance (pLI) score of 0.74, comparable to that of
histone H3 (H3F3A; pLI score 0.69), and more intolerant than
LMNA (pLI score 0.99; Florwick et al., 2017).
All 14 identified BANF1 missense variants were novel, and
most were non-conservative substitutions with the potential
to perturb BANF1 structure or function. The known or
predicted molecular impacts of BANF1 variants identified
in this study are summarized schematically in Figure 6.
Further studies are needed to determine if heterozygous
BANF1 variants are recessive or dominant. The only previously
reported human BANF variant, p.A12T, causes Nestor-
Guillermo progeria syndrome when homozygous (Puente
et al., 2011). When expressed ectopically in U2OS cells,
variant p.A12T caused a significant increase in the percentage
of cells with a misshapen nucleus (Paquet et al., 2014).
We therefore speculate that heterozygous variants (e.g.,
p.G25E, p.L63P, p.D9N) and homozygous variant p.D9H
might cause cellular phenotypes. The discovery of rare non-
conservative human BANF1 variants is exciting and warrants
further study in the contexts of nuclear lamina function, cell
cycle control, epigenetics, embryonic stem cells, mechano-
transduction or novel roles (Haraguchi et al., 2007; Cox
et al., 2011; Graham and Burridge, 2016; Brayson et al., 2018;
Wang et al., 2018).
ExAC Variants in or Near the Emerin
LEM-Domain
One intriguing question is whether the LEM-domain unfolds
or changes conformation in vivo. The rate of emerin filament
formation in vitro is accelerated by mutations that destabilize the
LEM-domain (Samson et al., 2017), and further accelerated in
the absence of the LEM-domain (Figures 2C,E; Samson et al.,
2018; Essawy et al., personal communication). As noted earlier,
several ExAC variants (e.g., p.P50H, p.S54C, p.S58F) near the
LEM-domain have the potential to disrupt a proposed ‘hinge’
region (Figures 2B–D), either by making it inflexible (Figure 4)
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FIGURE 5 | Variants located in or near the emerin C-terminus. (A) Kyte-Doolittle hydrophobicity plots of the transmembrane domains of wildtype (WT) emerin and
selected ExAC variants. (B) Predicted 1G for transmembrane helix insertion of WT emerin and each indicated ExAC variant. (C) Helical wheel projection of the
transmembrane domain of emerin (residues 226–244), plotted according to Pfaff and colleagues (Pfaff et al., 2016). WT residues affected by ExAC variants are bold,
with an arrow pointing to the substitution.
or by interfering with cellular control (e.g., phosphorylation vs.
O-GlcNAcylation at Ser54; Berk et al., 2013a).
Novel Variants-of-Interest in
Lamin-Binding Regions
The molecular basis for lamin A binding to emerin is beginning
to emerge. Lamin A binds emerin both directly via emerin
residues 55–132 (Figure 2G) or 159–220 (Figure 2H), and
indirectly through BANF1 (Samson et al., 2018). Furthermore,
the Ig-fold domain of lamin A associates with emerin filaments,
not emerin monomers (Samson et al., 2018; Essawy et al.,
personal communication). Thus, we predict that contact with
lamin A is perturbed by non-conservative substitutions in
peptides required for emerin self-association (e.g., p.P50S,
p.P50H, p.D149H, p.G156S, p.R207P, p.G216R, p.R221L), and by
variants in regions that bind lamins (e.g., p.N91S, p.R204G/C/H),
as illustrated schematically in Figure 6. For example, emerin
variants p.R207P and p.G216R are highly disruptive substitutions
in the conserved ‘R-peptide’, which is critical for emerin
self-association and binding to lamins (Figures 2B,E,H).
Several variants (e.g., p.S143F, p.D149H, p.G156R) have the
potential to affect binding to nesprins (Figure 2I; ‘Other
partners’ in Figure 6).
Variants Near Sites of Force-Stimulated
Emerin Tyr-Phosphorylation
‘Pulling’ on LINC complexes of isolated nuclei stiffens the
nucleus within seconds (Guilluy et al., 2014). This mechanical
response requires Src phosphorylation of emerin, and is
significantly reduced by substitutions that block phosphorylation
at two sites in emerin: Y74F and Y95F (Tifft et al., 2009;
Guilluy et al., 2014). The molecular mechanisms of emerin-
dependent stiffening are unknown, and might plausibly
involve force-induced and/or phosphorylation-induced changes
in emerin conformation, self-association and/or binding
to lamin A, BANF1 (chromatin), F-actin or myosin 1c
(Holaska and Wilson, 2007; Virtanen and Vartiainen, 2017;
Lambert, 2018). Testing these models will be an intriguing
challenge, since emerin is flexible and self-association is
required to bind many other partners including A-type
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FIGURE 6 | Schematic depiction of the inner nuclear membrane (INM) showing emerin, BANF1, an A-type lamin filament and selected partners (HDAC3, DNA,
histones). Emerin polypeptides and variants are shown in blue. BANF1 dimer and variants are shown in green. Lamin filament with four Ig-fold ‘tail’ domains is shown
in purple. Double-headed arrows indicate direct association, and each named variant is predicted (or in certain cases, known) to perturb the interaction. Emerin has
several modes of self-association and can form filaments (see text). Variant p.G25E inhibits BANF1 dimerization (indicated by the bar) resulting in loss of binding to
dsDNA, histones and the LEM-domain; the same is predicted for novel variant p.L63P. ‘Other’ partners not depicted include F-actin, nesprins, β-catenin and other
transcription factors (see text). Testing these predictions in future, especially for p.D149H and other ‘high-frequency’ emerin variants, may provide molecular insights
into nuclear lamina functions and human disease.
lamins (Figure 6). We speculate that variants such as p.N91S
and p.Y105C might perturb Src-dependent phosphorylation
at Y74 and Y95 (Table 2; Tifft et al., 2009). Novel ExAC
variants also provide a rich source of human variants to
test for potential defects in downstream emerin-dependent
transcription regulation (Ho et al., 2013; Willer and Carroll,
2017; Kirby and Lammerding, 2018).
Emerin Variant p.D149H Associated With
a ‘Healthy’ (Fasting) Lipid Phenotype
Emerin variant p.D149H, reported as benign with respect to
EDMD1, associated significantly with four traits in the Type 2
Diabetes Knowledge Portal: reduced triglycerides and reduced
waist circumference, as well as high-impact reductions in LDL
cholesterol and cholesterol. To our knowledge, this is the
first evidence that emerin directly influences metabolism. The
emerin p.D149H phenotype is opposite to that seen in LMNA-
associated metabolic disease, especially for triglycerides and waist
circumference, both of which are elevated in LMNA-associated
lipodystrophy, insulin resistance and metabolic syndrome
(Decaudain et al., 2007; Vadrot et al., 2015; Dutour et al., 2011;
Brayson and Shanahan, 2017). In contrast to our previous ExAC
study, which linked lamin A variant p.G602S with type 2 diabetes
(Florwick et al., 2017), we found no association of any emerin
variant with type 2 diabetes.
The traits associated with emerin p.D149H, especially the
reduction in LDL (‘bad’) cholesterol, are considered healthy.
The magnitude of LDL reduction associated with p.D149H is
comparable to the expected effects of drugs such as statins,
which aim to reduce LDL cholesterol by ≥50% to decrease
risk of adverse cardiovascular events (Ridker et al., 2016).
The triglyceride phenotype of emerin p.D149H is similar
to that caused by loss-of-function mutations in ANGPTL4
(angiopoietin-like protein 4), a secreted cytokine that helps
maintain low serum triglyceride levels by inhibiting the enzyme,
lipoprotein lipase (Dijk and Kersten, 2014). In mice, ANGPTL4
is expressed mainly in adipose tissue and is upregulated by
fasting in both white adipose tissue and liver (Dijk et al., 2018).
A missense mutation in ANGPTL4 (p.E40K), detected in∼3% of
European Americans, associates with reduced triglycerides and
increased HDL (‘good’) cholesterol (Romeo et al., 2007, 2009),
in proportions comparable to the effect of emerin p.D149H. The
p.E40K mutation in ANGPTL4 also associates with reduced risk
of coronary disease (Stitziel and Myocardial Infarction Genetics
and CARDIoGRAM Exome Consortia Investigators, 2016).
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The emerin p.D149H lipid phenotype raises important
questions. What do these ‘healthy’ lipid traits imply about
the normal roles of emerin in striated muscle (Brull et al.,
2018), or other tissues? Is this emerin phenotype related to the
immobilization of BANF1 at the nuclear lamina in response to
fasting in Caenorhabditis elegans intestinal cells (Bar et al., 2014)?
Is this ‘healthy lipid’ phenotype seen in both men and women, or
is it less pronounced in women, who express WT emerin in∼50%
of cells? We do not know which tissues are affected by emerin
p.D149H, although liver and adipose are plausible candidates.
Another open question is whether the p.D149H phenotype is
related to, or independent of, the metabolic phenotypes caused
by dominant LMNA variants. Future exploration of variant
p.D149H may provide insight into the protective roles of WT
emerin in the heart.
Where to Go From Here
Exome sequence data from human populations is an emerging
resource in biology, with the potential to advance personalized
medicine for individuals with well-characterized mutations. Our
analysis of EMD revealed an unexpected association between
emerin variant p.D149H and a ‘healthy lipid’ profile, and showed
that nearly 1% (∼0.83%) of East Asians in ExAC carry this
variant. Our previous study linked LMNA variant p.G602S to
type 2 diabetes and showed that ∼0.3% of African Americans
carry this allele, and revealed a dominant lipodystrophy-causing
variant (p.I299V) in 0.347% of Latinx individuals in ExAC
(Florwick et al., 2017). However, many fundamental aspects
of nuclear biology are unexplored or incompletely understood,
including the molecular connections between emerin, BANF1
and lamin filaments at the NE. Our analysis of three nuclear
lamina genes – LMNA (Florwick et al., 2017), EMD and BANF1
(this study) – in 60,706 unrelated individuals in ExAC has yielded
an unexpected trove of novel variants with the potential to
perturb specific interactions at the NE, as shown schematically
in Figure 6. These variants and predictions await testing.
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